Harvey M. Golomb to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Harvey M. Golomb has written about Dose-Response Relationship, Drug.
Connection Strength
0.062
-
Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood. 1990 Nov 15; 76(10):1941-5.
Score: 0.018
-
Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters. J Biol Response Mod. 1986 Jun; 5(3):270-81.
Score: 0.013
-
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80.
Score: 0.007
-
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Semin Oncol. 1996 Apr; 23(2 Suppl 5):11-8.
Score: 0.006
-
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study. Ann Oncol. 1996 Mar; 7(3):314-6.
Score: 0.006
-
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. Semin Oncol. 1995 Aug; 22(4 Suppl 9):38-41.
Score: 0.006
-
In vitro induction of proteins by alpha-interferon in hairy cell leukemia. Cancer Res. 1986 Aug; 46(8):4151-5.
Score: 0.003
-
Disseminated malignant lymphoma, histiocytic type: the changing picture. Ann Intern Med. 1976 Oct; 85(4):521-3.
Score: 0.002